Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Primary Pleomorphic Lipoma of the Parotid Gland with Prominent Myxoid Change: Report of a Rare Case Mimicking Carcinoma Ex Pleomorphic Adenoma on Fine Needle Aspiration Cytology.

Goh GH, Putti TC, Ngo R, Agaimy A, Petersson F.

Head Neck Pathol. 2019 Jan 4. doi: 10.1007/s12105-018-00998-9. [Epub ahead of print]

PMID:
30610525
2.

Elevated WBP2 Expression in HER2-positive Breast Cancers Correlates with Sensitivity to Trastuzumab-based Neoadjuvant Therapy: A Retrospective and Multicentric Study.

Kang SA, Guan JS, Tan HJ, Chu T, Thike AA, Bernadó C, Arribas J, Wong CY, Tan PH, Gudi M, Putti TC, Sohn J, Lim SH, Lee SC, Lim YP.

Clin Cancer Res. 2019 Apr 15;25(8):2588-2600. doi: 10.1158/1078-0432.CCR-18-3228. Epub 2018 Dec 28.

PMID:
30593516
3.

Multispectral Optoacoustic Tomography in Assessment of Breast Tumor Margins During Breast-Conserving Surgery: A First-in-human Case Study.

Goh Y, Balasundaram G, Moothanchery M, Attia A, Li X, Lim HQ, Burton N, Qiu Y, Putti TC, Chan CW, Iau P, Tang SW, Ng CWQ, Pool FJ, Pillay P, Chua W, Sterling E, Quek ST, Olivo M.

Clin Breast Cancer. 2018 Dec;18(6):e1247-e1250. doi: 10.1016/j.clbc.2018.07.026. Epub 2018 Aug 16. No abstract available.

4.

Phosphorylation of E-box binding USF-1 by PI3K/AKT enhances its transcriptional activation of the WBP2 oncogene in breast cancer cells.

Ramos A, Miow QH, Liang X, Lin QS, Putti TC, Lim YP.

FASEB J. 2018 Sep 5:fj201801167RR. doi: 10.1096/fj.201801167RR. [Epub ahead of print]

PMID:
30183375
5.

High Densities of Tumor-Associated Plasma Cells Predict Improved Prognosis in Triple Negative Breast Cancer.

Yeong J, Lim JCT, Lee B, Li H, Chia N, Ong CCH, Lye WK, Putti TC, Dent R, Lim E, Thike AA, Tan PH, Iqbal J.

Front Immunol. 2018 May 30;9:1209. doi: 10.3389/fimmu.2018.01209. eCollection 2018.

6.

rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk.

Liu J, Lončar I, Collée JM, Bolla MK, Dennis J, Michailidou K, Wang Q, Andrulis IL, Barile M, Beckmann MW, Behrens S, Benitez J, Blomqvist C, Boeckx B, Bogdanova NV, Bojesen SE, Brauch H, Brennan P, Brenner H, Broeks A, Burwinkel B, Chang-Claude J, Chen ST, Chenevix-Trench G, Cheng CY, Choi JY, Couch FJ, Cox A, Cross SS, Cuk K, Czene K, Dörk T, Dos-Santos-Silva I, Fasching PA, Figueroa J, Flyger H, García-Closas M, Giles GG, Glendon G, Goldberg MS, González-Neira A, Guénel P, Haiman CA, Hamann U, Hart SN, Hartman M, Hatse S, Hopper JL, Ito H, Jakubowska A, Kabisch M, Kang D, Kosma VM, Kristensen VN, Le Marchand L, Lee E, Li J, Lophatananon A, Jan Lubinski, Mannermaa A, Matsuo K, Milne RL; NBCS Collaborators, Neuhausen SL, Nevanlinna H, Orr N, Perez JI, Peto J, Putti TC, Pylkäs K, Radice P, Sangrajrang S, Sawyer EJ, Schmidt MK, Schneeweiss A, Shen CY, Shrubsole MJ, Shu XO, Simard J, Southey MC, Swerdlow A, Teo SH, Tessier DC, Thanasitthichai S, Tomlinson I, Torres D, Truong T, Tseng CC, Vachon C, Winqvist R, Wu AH, Yannoukakos D, Zheng W, Hall P, Dunning AM, Easton DF, Hooning MJ, van den Ouweland AM, Martens JW, Hollestelle A.

Sci Rep. 2016 Nov 15;6:36874. doi: 10.1038/srep36874.

7.

Low Levels of NDRG1 in Nerve Tissue Are Predictive of Severe Paclitaxel-Induced Neuropathy.

Sundar R, Jeyasekharan AD, Pang B, Soong RC, Kumarakulasinghe NB, Ow SG, Ho J, Lim JS, Tan DS, Wilder-Smith EP, Bandla A, Tan SS, Asuncion BR, Fazreen Z, Hoppe MM, Putti TC, Poh LM, Goh BC, Lee SC.

PLoS One. 2016 Oct 7;11(10):e0164319. doi: 10.1371/journal.pone.0164319. eCollection 2016.

8.

Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer.

Shi J, Zhang Y, Zheng W, Michailidou K, Ghoussaini M, Bolla MK, Wang Q, Dennis J, Lush M, Milne RL, Shu XO, Beesley J, Kar S, Andrulis IL, Anton-Culver H, Arndt V, Beckmann MW, Zhao Z, Guo X, Benitez J, Beeghly-Fadiel A, Blot W, Bogdanova NV, Bojesen SE, Brauch H, Brenner H, Brinton L, Broeks A, Brüning T, Burwinkel B, Cai H, Canisius S, Chang-Claude J, Choi JY, Couch FJ, Cox A, Cross SS, Czene K, Darabi H, Devilee P, Droit A, Dork T, Fasching PA, Fletcher O, Flyger H, Fostira F, Gaborieau V, García-Closas M, Giles GG; Mervi Grip, Guenel P, Haiman CA, Hamann U, Hartman M, Miao H, Hollestelle A, Hopper JL, Hsiung CN; kConFab Investigators, Ito H, Jakubowska A, Johnson N, Torres D, Kabisch M, Kang D, Khan S, Knight JA, Kosma VM, Lambrechts D, Li J, Lindblom A, Lophatananon A, Lubinski J, Mannermaa A, Manoukian S, Le Marchand L, Margolin S, Marme F, Matsuo K, McLean C, Meindl A, Muir K, Neuhausen SL, Nevanlinna H, Nord S, Børresen-Dale AL, Olson JE, Orr N, van den Ouweland AMW, Peterlongo P, Putti TC, Rudolph A, Sangrajrang S, Sawyer EJ, Schmidt MK, Schmutzler RK, Shen CY, Hou MF, Shrubsole MJ, Southey MC, Swerdlow A, Teo SH, Thienpont B, Toland AE, Tollenaar RAEM, Tomlinson I, Truong T, Tseng CC, Wen W, Winqvist R, Wu AH, Yip CH, Zamora PM, Zheng Y, Floris G, Cheng CY, Hooning MJ, Martens JWM, Seynaeve C, Kristensen VN, Hall P, Pharoah PDP, Simard J, Chenevix-Trench G, Dunning AM, Antoniou AC, Easton DF, Cai Q, Long J.

Int J Cancer. 2016 Sep 15;139(6):1303-1317. doi: 10.1002/ijc.30150. Epub 2016 Jun 17.

9.

Adult intraventricular astroblastoma.

Yeo JJ, Low YY, Putti TC, Koh KM.

Singapore Med J. 2016 Jan;57(1):53-4. doi: 10.11622/smedj.2016013. No abstract available.

10.

Genomic landscapes of breast fibroepithelial tumors.

Tan J, Ong CK, Lim WK, Ng CC, Thike AA, Ng LM, Rajasegaran V, Myint SS, Nagarajan S, Thangaraju S, Dey S, Nasir ND, Wijaya GC, Lim JQ, Huang D, Li Z, Wong BH, Chan JY, McPherson JR, Cutcutache I, Poore G, Tay ST, Tan WJ, Putti TC, Ahmad BS, Iau P, Chan CW, Tang AP, Yong WS, Madhukumar P, Ho GH, Tan VK, Wong CY, Hartman M, Ong KW, Tan BK, Rozen SG, Tan P, Tan PH, Teh BT.

Nat Genet. 2015 Nov;47(11):1341-5. doi: 10.1038/ng.3409. Epub 2015 Oct 5.

PMID:
26437033
11.

Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk.

Guo X, Long J, Zeng C, Michailidou K, Ghoussaini M, Bolla MK, Wang Q, Milne RL, Shu XO, Cai Q, Beesley J, Kar SP, Andrulis IL, Anton-Culver H, Arndt V, Beckmann MW, Beeghly-Fadiel A, Benitez J, Blot W, Bogdanova N, Bojesen SE, Brauch H, Brenner H, Brinton L, Broeks A, Brüning T, Burwinkel B, Cai H, Canisius S, Chang-Claude J, Choi JY, Couch FJ, Cox A, Cross SS, Czene K, Darabi H, Devilee P, Droit A, Dörk T, Fasching PA, Fletcher O, Flyger H, Fostira F, Gaborieau V, García-Closas M, Giles GG, Grip M, Guénel P, Haiman CA, Hamann U, Hartman M, Hollestelle A, Hopper JL, Hsiung CN, Ito H, Jakubowska A, Johnson N, Kabisch M, Kang D, Khan S, Knight JA, Kosma VM, Lambrechts D, Le Marchand L, Li J, Lindblom A, Lophatananon A, Lubinski J, Mannermaa A, Manoukian S, Margolin S, Marme F, Matsuo K, McLean CA, Meindl A, Muir K, Neuhausen SL, Nevanlinna H, Nord S, Olson JE, Orr N, Peterlongo P, Putti TC, Rudolph A, Sangrajrang S, Sawyer EJ, Schmidt MK, Schmutzler RK, Shen CY, Shi J, Shrubsole MJ, Southey MC, Swerdlow A, Teo SH, Thienpont B, Toland AE, Tollenaar RA, Tomlinson IP, Truong T, Tseng CC, van den Ouweland A, Wen W, Winqvist R, Wu A, Yip CH, Zamora MP, Zheng Y, Hall P, Pharoah PD, Simard J, Chenevix-Trench G; kConFab Investigators, Dunning AM, Easton DF, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1680-91. doi: 10.1158/1055-9965.EPI-15-0363. Epub 2015 Sep 9.

12.

Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk.

Lin WY, Camp NJ, Ghoussaini M, Beesley J, Michailidou K, Hopper JL, Apicella C, Southey MC, Stone J, Schmidt MK, Broeks A, Van't Veer LJ, Th Rutgers EJ, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Peto J, Dos-Santos-Silva I, Fletcher O, Johnson N, Bolla MK, Wang Q, Dennis J, Sawyer EJ, Cheng T, Tomlinson I, Kerin MJ, Miller N, Marmé F, Surowy HM, Burwinkel B, Guénel P, Truong T, Menegaux F, Mulot C, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Benitez J, Zamora MP, Arias Perez JI, Menéndez P, González-Neira A, Pita G, Alonso MR, Alvarez N, Herrero D, Anton-Culver H, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Meindl A, Lichtner P, Schmutzler RK, Müller-Myhsok B, Brauch H, Brüning T, Ko YD; GENICA Network, Tessier DC, Vincent D, Bacot F, Nevanlinna H, Aittomäki K, Blomqvist C, Khan S, Matsuo K, Ito H, Iwata H, Horio A, Bogdanova NV, Antonenkova NN, Dörk T, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM; kConFab Investigators; Australian Ovarian Cancer Study Group, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Neven P, Wauters E, Wildiers H, Lambrechts D, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Radice P, Peterlongo P, Manoukian S, Bonanni B, Couch FJ, Wang X, Vachon C, Purrington K, Giles GG, Milne RL, Mclean C, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Simard J, Goldberg MS, Labrèche F, Dumont M, Teo SH, Yip CH, Hassan N, Vithana EN, Kristensen V, Zheng W, Deming-Halverson S, Shrubsole MJ, Long J, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Kauppila S, Andrulis IL, Knight JA, Glendon G, Tchatchou S, Devilee P, Tollenaar RA, Seynaeve C, Van Asperen CJ, García-Closas M, Figueroa J, Lissowska J, Brinton L, Czene K, Darabi H, Eriksson M, Brand JS, Hooning MJ, Hollestelle A, Van Den Ouweland AM, Jager A, Li J, Liu J, Humphreys K, Shu XO, Lu W, Gao YT, Cai H, Cross SS, Reed MW, Blot W, Signorello LB, Cai Q, Pharoah PD, Perkins B, Shah M, Blows FM, Kang D, Yoo KY, Noh DY, Hartman M, Miao H, Chia KS, Putti TC, Hamann U, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Sangrajrang S, Gaborieau V, Brennan P, Mckay J, Slager S, Toland AE, Yannoukakos D, Shen CY, Hsiung CN, Wu PE, Ding SL, Ashworth A, Jones M, Orr N, Swerdlow AJ, Tsimiklis H, Makalic E, Schmidt DF, Bui QM, Chanock SJ, Hunter DJ, Hein R, Dahmen N, Beckmann L, Aaltonen K, Muranen TA, Heikkinen T, Irwanto A, Rahman N, Turnbull CA; Breast and Ovarian Cancer Susceptibility (BOCS) Study, Waisfisz Q, Meijers-Heijboer HE, Adank MA, Van Der Luijt RB, Hall P, Chenevix-Trench G, Dunning A, Easton DF, Cox A.

Hum Mol Genet. 2015 Jan 1;24(1):285-98. doi: 10.1093/hmg/ddu431. Epub 2014 Aug 28.

13.

Bronchiolitis obliterans organizing pneumonia following nitric acid fume exposure.

Lee LT, Ho CH, Putti TC.

Occup Med (Lond). 2014 Mar;64(2):136-8. doi: 10.1093/occmed/kqt147. Epub 2013 Dec 7.

PMID:
24319049
14.

One-step nucleic acid amplification assay also predicts axillary lymph node status in breast cancer patients: further molecular diagnostic evidence.

Wang T, Buhari SA, Pang B, Putti TC, Salto-Tellez M.

Eur J Cancer. 2013 Dec;49(18):3945-6. doi: 10.1016/j.ejca.2013.09.003. Epub 2013 Oct 9. No abstract available.

PMID:
24119461
15.

Papillary lesions of the breast: imaging findings and diagnostic challenges.

Jagmohan P, Pool FJ, Putti TC, Wong J.

Diagn Interv Radiol. 2013 Nov-Dec;19(6):471-8. doi: 10.5152/dir.2013.13041. Review.

16.

Manganese superoxide dismutase is a promising target for enhancing chemosensitivity of basal-like breast carcinoma.

Kumar AP, Loo SY, Shin SW, Tan TZ, Eng CB, Singh R, Putti TC, Ong CW, Salto-Tellez M, Goh BC, Park JI, Thiery JP, Pervaiz S, Clement MV.

Antioxid Redox Signal. 2014 May 20;20(15):2326-46. doi: 10.1089/ars.2013.5295. Epub 2013 Nov 14.

17.

Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls.

Zheng W, Zhang B, Cai Q, Sung H, Michailidou K, Shi J, Choi JY, Long J, Dennis J, Humphreys MK, Wang Q, Lu W, Gao YT, Li C, Cai H, Park SK, Yoo KY, Noh DY, Han W, Dunning AM, Benitez J, Vincent D, Bacot F, Tessier D, Kim SW, Lee MH, Lee JW, Lee JY, Xiang YB, Zheng Y, Wang W, Ji BT, Matsuo K, Ito H, Iwata H, Tanaka H, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Teo SH, Yip CH, Kang IN, Wong TY, Shen CY, Yu JC, Huang CS, Hou MF, Hartman M, Miao H, Lee SC, Putti TC, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Sangrajrang S, Shen H, Chen K, Wu PE, Ren Z, Haiman CA, Sueta A, Kim MK, Khoo US, Iwasaki M, Pharoah PD, Wen W, Hall P, Shu XO, Easton DF, Kang D.

Hum Mol Genet. 2013 Jun 15;22(12):2539-50. doi: 10.1093/hmg/ddt089. Epub 2013 Mar 27.

18.

Recent insights into the molecular pathogenesis of mammary phyllodes tumours.

Karim RZ, O'Toole SA, Scolyer RA, Cooper CL, Chan B, Selinger C, Yu B, Carmalt H, Mak C, Tse GM, Tan PH, Putti TC, Lee CS.

J Clin Pathol. 2013 Jun;66(6):496-505. doi: 10.1136/jclinpath-2012-201082. Epub 2013 Feb 12. Review.

PMID:
23404800
19.

Magnetic resonance in the detection of breast cancers of different histological types.

Mayrhofer RM, Ng HP, Putti TC, Kuchel PW.

Magn Reson Insights. 2013 Apr 30;6:33-49. doi: 10.4137/MRI.S10640. eCollection 2013. Review.

20.

E-cadherin expression in the epithelial components of mammary phyllodes tumors.

Tsang JY, Mendoza P, Putti TC, Karim RZ, Scolyer RA, Lee CS, Pang AL, Tse GM.

Hum Pathol. 2012 Dec;43(12):2117-23. doi: 10.1016/j.humpath.2012.03.028. Epub 2012 Jul 21.

PMID:
22820000
21.

Involvement of α- and β-catenins and E-cadherin in the development of mammary phyllodes tumours.

Tsang JY, Mendoza P, Lam CC, Yu AM, Putti TC, Karim RZ, Scolyer RA, Lee CS, Tan PH, Tse GM.

Histopathology. 2012 Oct;61(4):667-74. doi: 10.1111/j.1365-2559.2012.04271.x.

PMID:
22571452
22.

The ubiquitin peptidase UCHL1 induces G0/G1 cell cycle arrest and apoptosis through stabilizing p53 and is frequently silenced in breast cancer.

Xiang T, Li L, Yin X, Yuan C, Tan C, Su X, Xiong L, Putti TC, Oberst M, Kelly K, Ren G, Tao Q.

PLoS One. 2012;7(1):e29783. doi: 10.1371/journal.pone.0029783. Epub 2012 Jan 18.

23.

ERp29 induces breast cancer cell growth arrest and survival through modulation of activation of p38 and upregulation of ER stress protein p58IPK.

Gao D, Bambang IF, Putti TC, Lee YK, Richardson DR, Zhang D.

Lab Invest. 2012 Feb;92(2):200-13. doi: 10.1038/labinvest.2011.163. Epub 2011 Nov 7.

24.

Metastasis of occult prostatic carcinoma to the sphenoid sinus: report of a rare case and a review of the literature.

Petersson F, Hui TS, Loke D, Putti TC.

Head Neck Pathol. 2012 Jun;6(2):258-63. doi: 10.1007/s12105-011-0307-6. Epub 2011 Nov 5. Review.

25.

Common bile duct obstruction by intraluminal colorectal metastasis without evidence of liver or intraabdominal nodal metastasis.

Soh TI, Doshi BK, Putti TC, Ang BW, Aw DC, Cheong WK, Lee SC, Chuah BY.

Int J Colorectal Dis. 2012 Jan;27(1):127-8. doi: 10.1007/s00384-011-1205-9. Epub 2011 Apr 26. No abstract available.

PMID:
21519804
26.

Transcriptional consequences of genomic structural aberrations in breast cancer.

Inaki K, Hillmer AM, Ukil L, Yao F, Woo XY, Vardy LA, Zawack KF, Lee CW, Ariyaratne PN, Chan YS, Desai KV, Bergh J, Hall P, Putti TC, Ong WL, Shahab A, Cacheux-Rataboul V, Karuturi RK, Sung WK, Ruan X, Bourque G, Ruan Y, Liu ET.

Genome Res. 2011 May;21(5):676-87. doi: 10.1101/gr.113225.110. Epub 2011 Apr 5.

27.

Carpal tunnel syndrome caused by gouty tophus of the flexor tendons of the fingers: sonographic features.

Therimadasamy A, Peng YP, Putti TC, Wilder-Smith EP.

J Clin Ultrasound. 2011 Oct;39(8):463-5. doi: 10.1002/jcu.20799. Epub 2011 Mar 15.

PMID:
21412783
28.

Lack of RUNX3 inactivation in columnar cell lesions of breast.

Subramaniam MM, Chan JY, Omar MF, Ito K, Ito Y, Yeoh KG, Salto-Tellez M, Putti TC.

Histopathology. 2010 Oct;57(4):555-63. doi: 10.1111/j.1365-2559.2010.03675.x.

PMID:
20955380
29.

Aurora-A expression, hormone receptor status and clinical outcome in hormone related cancers.

Das K, Lorena PD, Ng LK, Shen L, Lim D, Siow WY, Narasimhan K, Teh M, Choolani M, Putti TC, Salto-Tellez M.

Pathology. 2010;42(6):540-6. doi: 10.3109/00313025.2010.508789.

PMID:
20854072
30.

Over-expression of ERp29 attenuates doxorubicin-induced cell apoptosis through up-regulation of Hsp27 in breast cancer cells.

Zhang D, Putti TC.

Exp Cell Res. 2010 Dec 10;316(20):3522-31. doi: 10.1016/j.yexcr.2010.08.014. Epub 2010 Sep 15.

PMID:
20833165
31.

PLCD1 is a functional tumor suppressor inducing G(2)/M arrest and frequently methylated in breast cancer.

Xiang T, Li L, Fan Y, Jiang Y, Ying Y, Putti TC, Tao Q, Ren G.

Cancer Biol Ther. 2010 Sep 1;10(5):520-7. doi: 10.4161/cbt.10.5.12726. Epub 2010 Sep 21.

PMID:
20657189
32.
33.

Mucinous cystadenocarcinoma of the breast with amplification of the HER2-gene confirmed by FISH: The first case reported.

Petersson F, Pang B, Thamboo TP, Putti TC.

Hum Pathol. 2010 Jun;41(6):910-3. doi: 10.1016/j.humpath.2009.10.020. Epub 2010 Mar 24.

PMID:
20338619
34.

A cognitive virtual microscopic framework for knowledge-based exploration of large microscopic images in breast cancer histopathology.

Roux L, Tutac A, Lomenie N, Balensi D, Racoceanu D, Veillard A, Leow WK, Klossa J, Putti TC.

Conf Proc IEEE Eng Med Biol Soc. 2009;2009:3697-702. doi: 10.1109/IEMBS.2009.5334739.

PMID:
19965006
35.
36.

Molecular-assisted immunohistochemical optimization.

Mohd Omar MF, Huang N, Ou K, Yu K, Putti TC, Jikuya H, Ichikawa T, Nishimura O, Tan P, Salto-Tellez M.

Acta Histochem. 2010 Nov;112(6):519-28. doi: 10.1016/j.acthis.2009.05.010. Epub 2009 Jul 22.

PMID:
19628254
37.

Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies.

Hentze H, Soong PL, Wang ST, Phillips BW, Putti TC, Dunn NR.

Stem Cell Res. 2009 May;2(3):198-210. doi: 10.1016/j.scr.2009.02.002. Epub 2009 Feb 12.

38.

Annexin-1 regulates growth arrest induced by high levels of estrogen in MCF-7 breast cancer cells.

Ang EZ, Nguyen HT, Sim HL, Putti TC, Lim LH.

Mol Cancer Res. 2009 Feb;7(2):266-74. doi: 10.1158/1541-7786.MCR-08-0147. Epub 2009 Feb 10.

39.

Automatic breast cancer grading of histopathological images.

Dalle JR, Leow WK, Racoceanu D, Tutac AE, Putti TC.

Conf Proc IEEE Eng Med Biol Soc. 2008;2008:3052-5. doi: 10.1109/IEMBS.2008.4649847.

PMID:
19163350
40.

Pathogenic mechanisms in the initiation and progression of mammary phyllodes tumours.

Karim RZ, Scolyer RA, Tse GM, Tan PH, Putti TC, Lee CS.

Pathology. 2009 Feb;41(2):105-17. doi: 10.1080/00313020802579342. Review.

PMID:
19152185
41.

Telomere-mediated genomic instability and the clinico-pathological parameters in breast cancer.

Poonepalli A, Banerjee B, Ramnarayanan K, Palanisamy N, Putti TC, Hande MP.

Genes Chromosomes Cancer. 2008 Dec;47(12):1098-109. doi: 10.1002/gcc.20608.

42.

Effect of lesion morphology on microwave signature in 2-D ultra-wideband breast imaging.

Chen Y, Gunawan E, Low KS, Wang SC, Soh CB, Putti TC.

IEEE Trans Biomed Eng. 2008 Aug;55(8):2011-21. doi: 10.1109/TBME.2008.921136.

PMID:
18632364
43.

TRARESA: a tissue microarray-based hospital system for biomarker validation and discovery.

Das K, Mohd Omar MF, Ong CW, Bin Abdul Rashid S, Peh BK, Putti TC, Tan PH, Chia KS, Teh M, Shah N, Soong R, Salto-Tellez M.

Pathology. 2008 Aug;40(5):441-9. doi: 10.1080/00313020802198101. Review.

PMID:
18604728
44.

Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors.

Tse GM, Lui PC, Vong JS, Lau KM, Putti TC, Karim R, Scolyer RA, Lee CS, Yu AM, Ng DC, Tse AK, Tan PH.

Breast Cancer Res Treat. 2009 Apr;114(3):441-8. doi: 10.1007/s10549-008-0030-5. Epub 2008 Apr 29.

PMID:
18443904
45.

Renal cell carcinoma bony metastasis treatment.

Nathan SS, Lim CT, Chuah BY, Putti TC, Stanley AJ, Wong AS.

Ann Acad Med Singapore. 2008 Mar;37(3):247-8. No abstract available.

46.

Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.

Ou K, Yu K, Kesuma D, Hooi M, Huang N, Chen W, Lee SY, Goh XP, Tan LK, Liu J, Soon SY, Bin Abdul Rashid S, Putti TC, Jikuya H, Ichikawa T, Nishimura O, Salto-Tellez M, Tan P.

J Proteome Res. 2008 Apr;7(4):1518-28. doi: 10.1021/pr700820g. Epub 2008 Mar 5.

PMID:
18318472
47.

RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression.

Subramaniam MM, Chan JY, Soong R, Ito K, Ito Y, Yeoh KG, Salto-Tellez M, Putti TC.

Breast Cancer Res Treat. 2009 Jan;113(1):113-21. doi: 10.1007/s10549-008-9917-4. Epub 2008 Feb 7.

PMID:
18256927
48.

Proteomic characterization of differentially expressed proteins in breast cancer: Expression of hnRNP H1, RKIP and GRP78 is strongly associated with HER-2/neu status.

Zhang D, Tai LK, Wong LL, Putti TC, Sethi SK, Teh M, Koay ES.

Proteomics Clin Appl. 2008 Jan;2(1):99-107. doi: 10.1002/prca.200780099.

PMID:
21136783
49.

The patella as an unusual site of renal cell carcinoma metastasis.

Lim CT, Wong AS, Chuah BY, Putti TC, Stanley AJ, Nathan SS.

Singapore Med J. 2007 Dec;48(12):e314-9.

50.

Clonal characterization of sporadic cribriform-morular variant of papillary thyroid carcinoma by laser microdissection-based APC mutation analysis.

Subramaniam MM, Putti TC, Anuar D, Chong PY, Shah N, Salto-Tellez M, Soong R.

Am J Clin Pathol. 2007 Dec;128(6):994-1001.

PMID:
18024325

Supplemental Content

Loading ...
Support Center